ENEXPRA Trademark

Trademark Overview

On Friday, March 14, 2008, a trademark application was filed for ENEXPRA with the United States Patent and Trademark Office. The USPTO has given the ENEXPRA trademark a serial number of 77422334. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, August 24, 2009. This trademark is owned by AstraZeneca AB. The ENEXPRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the fields of oncology, cardiovascular diseases, respiratory diseases, inflammation/infection, gastrointestinal diseases and central nervous system diseases
enexpra

General Information

Serial Number77422334
Word MarkENEXPRA
Filing DateFriday, March 14, 2008
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, August 24, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations in the fields of oncology, cardiovascular diseases, respiratory diseases, inflammation/infection, gastrointestinal diseases and central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, August 24, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Trademark Events

Event DateEvent Description
Monday, August 24, 2009ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Monday, August 24, 2009ABANDONMENT - AFTER PUBLICATION
Monday, August 24, 2009EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, July 28, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, July 9, 2009EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 9, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2009NOTICE OF PUBLICATION
Thursday, May 7, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 6, 2009DATA MODIFICATION COMPLETED
Tuesday, May 5, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 5, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, May 5, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 5, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, May 5, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, May 4, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 4, 2009NON-FINAL ACTION E-MAILED
Monday, May 4, 2009NON-FINAL ACTION WRITTEN
Thursday, April 30, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 29, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 29, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 30, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, October 30, 2008INQUIRY TO SUSPENSION E-MAILED
Thursday, October 30, 2008SUSPENSION INQUIRY WRITTEN
Thursday, May 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 30, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 30, 2008LETTER OF SUSPENSION E-MAILED
Wednesday, April 30, 2008SUSPENSION LETTER WRITTEN
Wednesday, April 30, 2008ASSIGNED TO EXAMINER
Thursday, April 3, 2008PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, April 2, 2008ASSIGNED TO LIE
Friday, March 28, 2008PAPER RECEIVED
Wednesday, March 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

enexpra diseases infection gastrointestinal central system nervous inflammation respiratory preparations fields